Loading data
MYPSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 235.1 m USD | 289.43 m USD | 310.89 m USD | 290.31 m USD | 287.42 m USD |
| Research and development expense | 58.38 m USD | 67.68 m USD | 70.3 m USD | 63.32 m USD | 61.34 m USD |
| Operating profit | -23.92 m USD | -32.86 m USD | -10.49 m USD | -28.08 m USD | -2.99 m USD |
| Profit before tax | -26.7 m USD | -27.29 m USD | -2.52 m USD | -23.62 m USD | 10.48 m USD |
| Income tax expense | 1.94 m USD | 1.4 m USD | 16.87 m USD | -5.84 m USD | -258 k USD |
| Net income (reported basis) | -28.64 m USD | -28.69 m USD | -19.39 m USD | -17.78 m USD | 10.74 m USD |
| Basic earnings per share | -0.23 USD/share | -0.22 USD/share | -0.15 USD/share | -0.14 USD/share | 0.1 USD/share |
| Diluted earnings per share | -0.23 USD/share | -0.22 USD/share | -0.15 USD/share | -0.14 USD/share | 0.09 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.